Related Experiment Videos
Pediatric transfusion: considerations by age and blood component
Insights
Pediatric transfusions need careful weight and age consideration due to volume issues. Proper diagnosis guides the choice of specific blood components like red blood cells and platelets for optimal pediatric patient care.
Area of Science:
- Pediatric Immunohematology
- Transfusion Medicine
- Pediatric Hemotherapy
Background:
- Pediatric transfusions require tailored approaches due to unique physiological considerations.
- Age and weight significantly impact intravascular volume and blood product administration in children.
- Diverse pediatric diseases necessitate specific blood component therapies.
Purpose of the Study:
- To outline key considerations for blood transfusion in pediatric patients.
- To detail the selection and use of various blood components in children.
- To highlight advanced therapeutic modalities and adverse reactions in pediatric transfusion medicine.
Main Methods:
- Review of current practices in pediatric transfusion medicine.
- Analysis of indications for common blood components (red blood cells, platelets, granulocytes, factor VIII, prothrombin complex).
- Inclusion of novel treatments like bone marrow transplantation and apheresis.
Main Results:
- Specific blood components are indicated based on distinct pediatric disease processes.
- Accurate diagnosis is crucial for appropriate blood component selection.
- Bone marrow transplantation and apheresis represent advanced immunohematology-hemotherapy options.
Conclusions:
- Blood component choice in pediatrics must align with clinical need and benefit-to-risk assessment.
- Careful consideration of patient factors (age, weight) is paramount for safe and effective pediatric transfusions.
- Understanding diverse disease processes and available components optimizes therapeutic outcomes.
Abstract:
Transfusion in the pediatric age group requires careful consideration of the patient's weight and age because of potential problems with intravascular volume and difficulty with administration of the blood product. Different age groups have varied disease processes that require specific blood components. A correct diagnosis is essential for their proper choice and use. Common blood components used include red blood cells, platelets, granulocytes, factor VIII preparations, and prothrombin complex concentrates. Bone marrow transplantation and apheresis are new therapeutic modalities available through immunohematology-hemotherapy units. Adverse reactions to blood components include immediate and delayed types. The choice of a blood component should be related to clinical need, with overall concern for benefit-to-risk potential for the pediatric patient.